VU
Venkateswarlu Usurupati
About Venkateswarlu Usurupati
Data last updated:
Venkateswarlu Usurupati is a Director at Paramesu Biotech Limited (since 2024). The company operates in Chemicals and Materials. Paramesu Biotech Limited reported revenue of ₹769 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 27 Aug 2024 | 2011 | ₹769 Cr (FY 2025) | Active |
Board colleagues of Venkateswarlu Usurupati
| Name | DIN | Company | Designation |
|---|---|---|---|
| Amulya Dasari | Paramesu Biotech Limited | Company Secretary | |
| Ananda Swaroop Adavani | 02949170 | Paramesu Biotech Limited | Managing Director |
| Lakshmipathi Reddy Garachetla | 09101769 | Paramesu Biotech Limited | Director |
| Maniswetha Tetai | 02949349 | Paramesu Biotech Limited | Whole-Time Director |
| Sanyukta Jodhani | Paramesu Biotech Limited | Company Secretary | |
| Satya Suresh Veeravilli | 10826361 | Paramesu Biotech Limited | Whole-Time Director |
| Satya Suresh Veeravilli | Paramesu Biotech Limited | Cfo | |
| Yedla Maithri | 10798905 | Paramesu Biotech Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Venkateswarlu Usurupati
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Venkateswarlu Usurupati
Venkateswarlu Usurupati currently holds 1 directorship: Paramesu Biotech Limited (Director, since 27 Aug 2024, revenue ₹769 Cr (FY 2025)).
Venkateswarlu Usurupati was first appointed on 27 Aug 2024 as Director at Paramesu Biotech Limited.
The current boards of Venkateswarlu Usurupati's companies include Amulya Dasari (Paramesu Biotech Limited), Ananda Swaroop Adavani (Paramesu Biotech Limited), Lakshmipathi Reddy Garachetla (Paramesu Biotech Limited), Maniswetha Tetai (Paramesu Biotech Limited), Sanyukta Jodhani (Paramesu Biotech Limited), Satya Suresh Veeravilli (Paramesu Biotech Limited), among others.